NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.68% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.53% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.53% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.52% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.51% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.49% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 1.49% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.48% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.46% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.46% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.46% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.45% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.42% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.41% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.41% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.38% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.37% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.27% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.16% |